← Open Payments lookup

JILL BRABANT: Open Payments

NPI 1326120692 · GOUVERNEUR, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$957 in 52 payments from 12 companies in 2025. Trend: 2023 $707 · 2024 $813 · 2025 $957

Food & beverage: $957
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.18$361
Teva Pharmaceuticals USA, Inc.10$153
Otsuka America Pharmaceutical, Inc.6$110
ABBVIE INC.3$59
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$58
Janssen Pharmaceuticals, Inc2$53
Alkermes, Inc.3$46
Vanda Pharmaceuticals Inc.3$45
Lundbeck LLC1$26
Supernus Pharmaceuticals, Inc.1$16

Products named: COBENFY, REXULTI, UZEDY, AUSTEDO XR, VRAYLAR, CAPLYTA, INVEGA SUSTENNA, LYBALVI.

Industry payments across NY — which companies pay providers there.